div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer src=https:reader030fdocumentsinreader030viewer202203261256812cad550346895d915fd7html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divpRationale for Radiopharmaceuticals inp pMetastatic Castration-Resistant Prostate Cancerpdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer src=https:reader030fdocumentsinreader030viewer202203261256812cad550346895d915fd7html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divpProgram Goalspdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer src=https:reader030fdocumentsinreader030viewer202203261256812cad550346895d915fd7html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer src=https:reader030fdocumentsinreader030viewer202203261256812cad550346895d915fd7html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer src=https:reader030fdocumentsinreader030viewer202203261256812cad550346895d915fd7html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 6button div class=trans-image amp-img class=trans-thumb alt=Page 6: Rationale for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer...